Global Custom Market Research Reports Provider Company

phone

Surgical Mesh - Medical Devices Pipeline Assessment, 2017

  • Published Date: 01 Aug 2017
  • Number of Pages: 189
  • Category: Healthcare and Medical
  • Country: Global
Surgical Mesh - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Surgical Mesh - Medical Devices Pipeline Assessment, 2017" provides an overview of Surgical Mesh currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Surgical Mesh pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Surgical Mesh under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Surgical Mesh and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Surgical Mesh under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Surgical Mesh Overview 9
3 Products under Development 10
3.1 Surgical Mesh - Pipeline Products by Stage of Development 10
3.2 Surgical Mesh - Pipeline Products by Territory 11
3.3 Surgical Mesh - Pipeline Products by Regulatory Path 12
3.4 Surgical Mesh - Pipeline Products by Estimated Approval Date 13
3.5 Surgical Mesh - Ongoing Clinical Trials 14
4 Surgical Mesh - Pipeline Products under Development by Companies 15
4.1 Surgical Mesh Companies - Pipeline Products by Stage of Development 15
4.2 Surgical Mesh - Pipeline Products by Stage of Development 17
5 Surgical Mesh Companies and Product Overview 18
5.1 Acera Surgical, Inc. Company Overview 18
5.1.1 Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Admedus Ltd Company Overview 19
5.2.1 Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Anika Therapeutics Inc Company Overview 20
5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Boston Scientific Corp Company Overview 21
5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Colorado Therapeutics, LLC Company Overview 22
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 CorMedix Inc Company Overview 23
5.6.1 CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 DSM Biomedical BV Company Overview 24
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 Ethicon US LLC Company Overview 28
5.8.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Fibralign Corporation Company Overview 30
5.9.1 Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Harbor MedTech Inc Company Overview 33
5.10.1 Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 John Hopkins University Company Overview 36
5.11.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Medisse BV (Inactive) Company Overview 37
5.12.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Medlinx Acacia Pte Ltd Company Overview 39
5.13.1 Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 Medtronic plc Company Overview 40
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Polyganics BV Company Overview 42
5.15.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42
5.16 PolyNovo Biomaterials Pty Ltd Company Overview 43
5.16.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
5.17 Proxy Biomedical Ltd Company Overview 44
5.17.1 Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Refine LLC Company Overview 45
5.18.1 Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Retectix, LLC Company Overview 46
5.19.1 Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Revivicor Inc Company Overview 47
5.20.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.21 Samyang Biopharmaceuticals Corp Company Overview 48
5.21.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 Silver Bullet Therapeutics, Inc. Company Overview 49
5.22.1 Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 Soft Tissue Regeneration Inc Company Overview 50
5.23.1 Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Teleflex Inc Company Overview 51
5.24.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Tepha Inc Company Overview 52
5.25.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.26 The Electrospinning Company Ltd Company Overview 53
5.26.1 The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
5.27 University of Maryland Baltimore Company Overview 54
5.27.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54
5.28 University of South Florida Company Overview 55
5.28.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55
6 Surgical Mesh- Recent Developments 56
6.1 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 56
6.2 Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 57
6.3 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 63
6.4 Jul 21, 2017: Endo to Restructure Manufacturing Network 65
6.5 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 65
6.6 Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 66
6.7 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 66
6.8 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 67
6.9 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 69
6.10 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 70
6.11 Jun 07, 2017: Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation 70
6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 71
6.13 May 25, 2017: BioLineRx Reports First Quarter 2017 Financial Results 74
6.14 May 15, 2017: Colorado Therapeutics Appoints Medtronic Executive John Lorbiecki as Chief Operating Officer in Advance of XI-S+ Launch 76
6.15 May 12, 2017: Integra LifeSciences launches SurgiMend MP Collagen Matrix for Hernia Repair 76
6.16 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 77
6.17 May 09, 2017: Endo Reports First-Quarter 2017 Financial Results 77
6.18 May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results 80
6.19 May 03, 2017: Anika Reports First Quarter 2017 Financial Results 83
6.20 May 03, 2017: Coloplast delivers satisfactory Q2 result 84
6.21 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017 84
6.22 Apr 27, 2017: Tepha Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM 3D Surgical Scaffold 86
6.23 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 87
6.24 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 88
6.25 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 89
6.26 Apr 24, 2017: Proxy Biomedical Group Announces New Corporate Brand Aran Biomedical 90
6.27 Apr 24, 2017: Collagen Solutions: Consolidation of US R&D activities and Board change 91
6.28 Apr 23, 2017: Bard Announces First Quarter Results 91
6.29 Apr 20, 2017: Long-term study shows continuous improvement of quality of life following cystocele repair with alloplastic mesh implant 92
6.30 Apr 18, 2017: RTI Surgical Expands Line of Matrices in International Markets 93
6.31 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance 94
6.32 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 95
6.33 Mar 31, 2017: B. Braun continues its sales and earnings growth 95
6.34 Mar 29, 2017: Tepha Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE 3D Surgical Scaffold 97
6.35 Mar 23, 2017: BioLineRx Reports Year End 2016 Financial Results 98
6.36 Mar 20, 2017: Collagen Solutions introduces new online sales initiative in the US 100
6.37 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors 100
6.38 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 101
6.39 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 103
6.40 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 103
6.41 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 104
6.42 Feb 28, 2017: Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results 105
6.43 Feb 24, 2017: Admedus Announces Half Yearly Report 108
6.44 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 110
6.45 Feb 23, 2017: MiMedx Announces 2016 Record Results 112
6.46 Feb 22, 2017: Change in the B. Braun Management Board 114
6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 114
6.48 Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance 117
6.49 Feb 20, 2017: ACERA Selected as One of the Best University Startups 2016 by National Council of Entrepreneurial Tech Transfer 119
6.50 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.51 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results 120
6.52 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011 121
6.53 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 123
6.54 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 123
6.55 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 124
6.56 Jan 26, 2017: Bard Announces Fourth Quarter Results 125
6.57 Jan 26, 2017: Endo Announces Actions to Drive Greater Efficiency and Business Alignment 126
6.58 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 127
6.59 Jan 19, 2017: Collagen Solutions Team Strengthened with New Scientific Advisory Board Appointments 128
6.60 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 128
6.61 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance 129
6.62 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 130
6.63 Dec 21, 2016: Endo Announces Appointments and Updates to Executive Management Team 131
6.64 Dec 20, 2016: FDA Approval for Endoform Plastics and Reconstructive Matrix 132
6.65 Dec 20, 2016: Endo Announces Appointment of Blaise Coleman as Chief Financial Officer 133
6.66 Dec 19, 2016: Collagen Solutions Announces Interim Results for the six months ended 30 September 2016 133
6.67 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90% 134
6.68 Dec 15, 2016: W. L. Gore & Associates Receives Innovative Technology Designation from Vizient for GORE SYNECOR Biomaterial 135
6.69 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 136
6.70 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 136
6.71 Nov 22, 2016: BioLineRx Reports Third Quarter 2016 Financial Results 139
6.72 Nov 21, 2016: TELA Bio Announces Settlement of Litigation with LifeCell 141
6.73 Nov 16, 2016: Tepha Subsidiary, Galatea Surgical, Announces Presentation of GalaFLEX Surgical Scaffold Clinical Data at London Breast Meeting 142
6.74 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 142
6.75 Nov 08, 2016: Endo Reports Third Quarter 2016 Financial Results 143
6.76 Nov 07, 2016: Endo Strengthens Leadership Team with Appointment of Two Key Executives 144
6.77 Nov 03, 2016: DSM Q3 2016 Results 145
6.78 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published 147
6.79 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 148
6.80 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 150
6.81 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results 151
6.82 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 154
6.83 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 156
6.84 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 157
6.85 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 157
6.86 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 159
6.87 Oct 25, 2016: Bard Announces Third Quarter Results 159
6.88 Oct 21, 2016: Colorado Therapeutics Receives 510(k) Clearance for a Novel Xenograft Implant for Soft Tissue Repairs 160
6.89 Oct 20, 2016: Endo Announces Departure of Chief Financial Officer 160
6.90 Oct 10, 2016: Long-term cystocele repair and improved quality of life 161
6.91 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 162
6.92 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance 163
6.93 Sep 30, 2016: Hernia Mesh Lawsuit Filed on Behalf of Ethicon Physiomesh Patient Scheduled for January 2018 Trial, Bernstein Liebhard Reports 164
6.94 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 165
6.95 Sep 25, 2016: Admedus Strengthens Management Team 166
6.96 Sep 23, 2016: Endo Names Paul Campanelli President and Chief Executive Officer 166
6.97 Sep 19, 2016: Organogenesis Announces New Chief Financial Officer 167
6.98 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 168
6.99 Sep 13, 2016: FDA Clears Omega3-rich Fish Skin for Surgical Applications 169
6.100 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 169
6.101 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance 170
6.102 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 170
6.103 Sep 01, 2016: Fibralign Announces Enrollment Initiated for Stanford-Led Clinical Trial for Breast Cancer-Related Lymphedema 171
6.104 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 172
6.105 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 172
6.106 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 173
6.107 Aug 18, 2016: Deceptive marketing of surgical transvaginal mesh leads to trouble for Johnson & Johnson 175
6.108 Aug 16, 2016: Coloplast delivers 9M result in line with guidance 176
6.109 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 177
6.110 Aug 11, 2016: BioLineRx Names Philip A. Serlin as Chief Executive Officer 177
6.111 Aug 11, 2016: BioLineRx Reports Second Quarter 2016 Financial Results 178
6.112 Aug 08, 2016: Endo Reports Second Quarter 2016 Financial Results 180
6.113 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance 182
7 Appendix 186
7.1 Methodology 186
7.2 About GlobalData 189
7.3 Contact Us 189
7.4 Disclaimer 189

List Of Tables


Table 1: Surgical Mesh - Pipeline Products by Stage of Development 10
Table 2: Surgical Mesh - Pipeline Products by Territory 11
Table 3: Surgical Mesh - Pipeline Products by Regulatory Path 12
Table 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13
Table 5: Surgical Mesh - Ongoing Clinical Trials 14
Table 6: Surgical Mesh Companies - Pipeline Products by Stage of Development 15
Table 7: Surgical Mesh - Pipeline Products by Stage of Development 17
Table 8: Acera Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 9: Surgical Mesh - Orthopedic Surgery - Product Status 18
Table 10: Surgical Mesh - Orthopedic Surgery - Product Description 18
Table 11: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 12: GyneCel - Product Status 19
Table 13: GyneCel - Product Description 19
Table 14: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 15: HYAFF Mesh - Product Status 20
Table 16: HYAFF Mesh - Product Description 20
Table 17: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21
Table 18: Next Generation Abdominal Mesh - Product Status 21
Table 19: Next Generation Abdominal Mesh - Product Description 21
Table 20: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 21: XI-S+ - Product Status 22
Table 22: XI-S+ - Product Description 22
Table 23: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 24: Taurolidine Surgical Mesh - Product Status 23
Table 25: Taurolidine Surgical Mesh - Product Description 23
Table 26: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 24
Table 27: Bioadhesive Surgical Mesh - Tendon Repair - Product Status 24
Table 28: Bioadhesive Surgical Mesh - Tendon Repair - Product Description 24
Table 29: Meso BioMatrix - Breast Surgery - Product Status 25
Table 30: Meso BioMatrix - Breast Surgery - Product Description 25
Table 31: DSM Biomedical BV - Ongoing Clinical Trials Overview 26
Table 32: Meso BioMatrix - Breast Surgery - Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial 27
Table 33: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: GYNECARE Next Generation Pelvic Floor Repair Device - Product Status 28
Table 35: GYNECARE Next Generation Pelvic Floor Repair Device - Product Description 28
Table 36: GYNECARE PROLIFT Next Generation - Product Status 29
Table 37: GYNECARE PROLIFT Next Generation - Product Description 29
Table 38: Fibralign Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 39: BioBridge Collagen Matrix - Secondary Lymphedema - Product Status 30
Table 40: BioBridge Collagen Matrix - Secondary Lymphedema - Product Description 30
Table 41: Fibralign Corporation - Ongoing Clinical Trials Overview 31
Table 42: BioBridge Collagen Matrix - Secondary Lymphedema - Prospective Evaluation of the Biobridge Scaffold as an Adjunct to Vascularized Lymph Node Transfer for Upper Extremity Lymphedema 32
Table 43: Harbor MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 44: EPMatrix - Breast Reconstruction - Product Status 33
Table 45: EPMatrix - Breast Reconstruction - Product Description 33
Table 46: Surgical Mesh - Joint Repair - Product Status 34
Table 47: Surgical Mesh - Joint Repair - Product Description 34
Table 48: Surgical Mesh - Urogynecological Repair - Product Status 34
Table 49: Surgical Mesh - Urogynecological Repair - Product Description 35
Table 50: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 36
Table 51: 3D Facial Reconstruction Pre-Form Mesh - Product Status 36
Table 52: 3D Facial Reconstruction Pre-Form Mesh - Product Description 36
Table 53: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
Table 54: Composite Hernia Mesh - Product Status 37
Table 55: Composite Hernia Mesh - Product Description 37
Table 56: PTMC Prolapse - Product Status 38
Table 57: PTMC Prolapse - Product Description 38
Table 58: Medlinx Acacia Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 59: PVDV Hernia Mesh - Product Status 39
Table 60: PVDV Hernia Mesh - Product Description 39
Table 61: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 62: Hernia Repair Device - Product Status 40
Table 63: Hernia Repair Device - Product Description 40
Table 64: ProGrip Mesh - Product Status 41
Table 65: ProGrip Mesh - Product Description 41
Table 66: Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 42
Table 67: Surgical Mesh - Product Status 42
Table 68: Surgical Mesh - Product Description 42
Table 69: PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 70: NovoFlex - Product Status 43
Table 71: NovoFlex - Product Description 43
Table 72: Proxy Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: ExtreMESH - Product Status 44
Table 74: ExtreMESH - Product Description 44
Table 75: Refine LLC Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Refine Support System - Product Status 45
Table 77: Refine Support System - Product Description 45
Table 78: Retectix, LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Table 79: DuraStar Dural Substitue - Product Status 46
Table 80: DuraStar Dural Substitue - Product Description 46
Table 81: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 82: Hernia Repair Scaffold - Product Status 47
Table 83: Hernia Repair Scaffold - Product Description 47
Table 84: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 48
Table 85: Absorbable Surgical Mesh - Product Status 48
Table 86: Absorbable Surgical Mesh - Product Description 48
Table 87: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 88: Galvanis Mesh - Product Status 49
Table 89: Galvanis Mesh - Product Description 49
Table 90: Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 91: 3D Surgical Mesh - Breast Reconstruction - Product Status 50
Table 92: 3D Surgical Mesh - Breast Reconstruction - Product Description 50
Table 93: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 94: Double-Sided Hernia Mesh - Product Status 51
Table 95: Double-Sided Hernia Mesh - Product Description 51
Table 96: Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 97: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Status 52
Table 98: TephaFLEX Absorbable Knitted Multifilament Mesh - Product Description 52
Table 99: The Electrospinning Company Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
Table 100: Bio-Synthetic Surgical Mesh - Product Status 53
Table 101: Bio-Synthetic Surgical Mesh - Product Description 53
Table 102: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 54
Table 103: Hybrid Mesh - Product Status 54
Table 104: Hybrid Mesh - Product Description 54
Table 105: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 55
Table 106: SiC Nanoparticle Impregnated Surgical Mesh - Product Status 55
Table 107: SiC Nanoparticle Impregnated Surgical Mesh - Product Description 55
Table 108: Glossary 188

List Of Figures


Figure 1: Surgical Mesh - Pipeline Products by Stage of Development 10
Figure 2: Surgical Mesh - Pipeline Products by Territory 11
Figure 3: Surgical Mesh - Pipeline Products by Regulatory Path 12
Figure 4: Surgical Mesh - Pipeline Products by Estimated Approval Date 13
Figure 5: Surgical Mesh - Ongoing Clinical Trials 14

This report studies Surgical Instrument Tracking System in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these

View Report

This report studies Surgical Sutures in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from

View Report

In this report, the EMEA Neurosurgical Navigation Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports